ECONSALUT
Critical comments on health economics and policy
26 de març 2013
The economists' capture
›
Luigi Zingales has written a salient chapter on a book on preventing regulatory capture . His focus is not on the regulator, he describes th...
25 de març 2013
Choice architecture
›
A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy Is there a need to change " choice architecture " to adopt healt...
22 de març 2013
A country in a desperate situation
›
Early this morning on the radio this was the statement: "We live in a country in a desperate situation". The reason is that the ru...
21 de març 2013
A market that grows
›
This is the case of voluntary health insurance. Amid the current downturn, in 2012 there was an increase in the number of members (2.04%) an...
20 de març 2013
P4P: Ethics and effectiveness
›
Ethical Physician Incentives — From Carrots and Sticks to Shared Purpose The strict focus on carrots and sticks in the design of physician...
18 de març 2013
The size of the pie
›
From the WEF report last year on non communicable diseases, I retrieve the size of worlwide health expenditure in 2009: World expenditu...
13 de març 2013
The ownership of drugs data
›
Starting in 2014, clinical trials data of drugs approved by European agency will have to be released publicly. This has been a major claim b...
12 de març 2013
Back to essentials (2)
›
In many cases, delay is not feasible. Decisions need to be made, even if the environment is one of limited attention, information, and proce...
11 de març 2013
Back to essentials
›
Fortunately, we have started a new paradigm.A little bit late, but last Friday the government announced what I call clever budget cuts . The...
10 de març 2013
It's all about economies of scale
›
Last week I participated in a round table on pharmacy. The biggest concern right now is when the government will pay the bill. The pharmacis...
07 de març 2013
Still waiting after all these months
›
Waiting lists may be considered the most prominent consequence of a publicly funded health system. Without price barriers, the queue for an ...
04 de març 2013
The patent cliff is not over
›
Imagine for a while that the size of a market drops by 290 billion between 2012 and 2018. This is the case of pharmaceuticals. This is not n...
27 de febrer 2013
A startling achievement
›
INFORME MENSUAL DE SEGUIMENT DE LA PRESTACIÓ FARMACÈUTICA Pharmaceutical expenditure in 2012 has dropped 14,27%, double of last year. That...
26 de febrer 2013
The collapse of managed competition
›
The colombian Health Minister has just announced the end of competition between insurers under a mandatory health insurance scheme. This is...
‹
›
Inici
Visualitza la versió per a web